SOCS3 suppresses glioblastoma growth via JAK-STAT inhibition and mitochondrial unfolded protein response activation

Read full text Summarise with VIRAT
Authors: Gaolei Hou, Zhaofei Song, Jingtao Wang, Junmei Wang, Hongbin Wang, Tao Li
Cited by: 0
References: 65

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Glioblastoma (GBM) represents one of the most aggressive brain malignancies, characterized by rapid proliferation and pronounced resistance to apoptosis, resulting in poor therapeutic outcomes. Suppressor of cytokine signaling 3 (SOCS3), a crucial negative regulator of the JAK-STAT pathway, frequently undergoes epigenetic silencing in GBM. However, the tumor-suppressive functions of SOCS3 remain inadequately defined. The present study explores the role of SOCS3 in regulating mitochondrial stress responses and evaluates its therapeutic potential in GBM. METHODS: SOCS3 was overexpressed in GBM cell lines, and its effects on cell viability and apoptosis were assessed using MTT assays, TUNEL staining, and Western blotting. Proteomic profiling was performed to identify SOCS3-regulated pathways. A xenograft mouse model was used to validate tumor-suppressive effects in vivo. The impact of IL-6 (JAK-STAT activator) and Nicotinamide Riboside (NR, a mitochondrial stress inducer) was also examined. RESULTS: SOCS3 overexpression significantly suppressed GBM cell proliferation and induced apoptosis. Proteomic analysis revealed upregulation of mitochondrial unfolded protein response (UPRmt) and mitophagy-related proteins. In vivo, SOCS3 reduced tumor growth and enhanced apoptotic signaling. IL-6 treatment restored JAK-STAT activity and reversed SOCS3-mediated tumor suppression. In contrast, NR treatment synergistically augmented SOCS3-induced mitochondrial stress and apoptosis, suggesting that mitochondrial dysfunction contributes to enhanced cell death. CONCLUSION: SOCS3 exerts dual tumor-suppressive effects in GBM by inhibiting JAK-STAT signaling and activating mitochondrial stress pathways. These findings provide mechanistic insights into the function of SOCS3 and support its potential as a therapeutic target in GBM by promoting UPRmt-driven apoptosis.

Fields of Study & Subjects

Cytokine Signaling Pathways and Interactions Glioma Diagnosis and Treatment Pharmacological Receptor Mechanisms and Effects

Publication details

Journal / source
Cell Division
Volume
21
Issue
1
Publication date
25 March 2026
Language
EN